BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31351104)

  • 1. Utility of Three-Dimensional Skin From Human-Induced Pluripotent Stem Cells as a Tool to Evaluate Transdermal Drug Permeation.
    Naito C; Yamaguchi T; Katsumi H; Kimura S; Kamei S; Morishita M; Sakane T; Kawabata K; Yamamoto A
    J Pharm Sci; 2019 Nov; 108(11):3524-3527. PubMed ID: 31351104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Induced Pluripotent Stem Cell-Based Skin for Assessing Transdermal Drug Permeability and Irritancy.
    Naito C; Yamaguchi T; Katsumi H; Kimura S; Kamei S; Morishita M; Kawabata K; Yamamoto A
    Biol Pharm Bull; 2021; 44(1):140-143. PubMed ID: 33390542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transdermal delivery of relatively high molecular weight drugs using novel self-dissolving microneedle arrays fabricated from hyaluronic acid and their characteristics and safety after application to the skin.
    Liu S; Jin MN; Quan YS; Kamiyama F; Kusamori K; Katsumi H; Sakane T; Yamamoto A
    Eur J Pharm Biopharm; 2014 Feb; 86(2):267-76. PubMed ID: 24120887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stratum corneum permeation and percutaneous drug delivery of hydrophilic molecules enhanced by cryopneumatic and photopneumatic technologies.
    Sun F; Anderson R; Aguilar G
    J Drugs Dermatol; 2010 Dec; 9(12):1528-30. PubMed ID: 21120262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Permeation enhancer strategies in transdermal drug delivery.
    Marwah H; Garg T; Goyal AK; Rath G
    Drug Deliv; 2016; 23(2):564-78. PubMed ID: 25006687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement.
    Aboofazeli R; Zia H; Needham TE
    Drug Deliv; 2002; 9(4):239-47. PubMed ID: 12511202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of a complex skin structure via layered co-culture of keratinocytes and fibroblasts derived from induced pluripotent stem cells.
    Kim Y; Park N; Rim YA; Nam Y; Jung H; Lee K; Ju JH
    Stem Cell Res Ther; 2018 Aug; 9(1):217. PubMed ID: 30103800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melanin Transfer in Human 3D Skin Equivalents Generated Exclusively from Induced Pluripotent Stem Cells.
    Gledhill K; Guo Z; Umegaki-Arao N; Higgins CA; Itoh M; Christiano AM
    PLoS One; 2015; 10(8):e0136713. PubMed ID: 26308443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of pretreatment of needle puncture and sandpaper abrasion on the in vitro skin permeation of fluorescein isothiocyanate (FITC)-dextran.
    Wu XM; Todo H; Sugibayashi K
    Int J Pharm; 2006 Jun; 316(1-2):102-8. PubMed ID: 16597490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Umbilical therapy for promoting transdermal delivery of topical formulations: Enhanced effect and underlying mechanism.
    Yang C; Peng X; Shi Y; Zhang Y; Feng M; Tian Y; Zhang J; Cen S; Li Z; Dai X; Jing Z; Shi X
    Int J Pharm; 2024 Mar; 652():123834. PubMed ID: 38262583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trypsin as a novel potential absorption enhancer for improving the transdermal delivery of macromolecules.
    Li YZ; Quan YS; Zang L; Jin MN; Kamiyama F; Katsumi H; Tsutsumi S; Yamamoto A
    J Pharm Pharmacol; 2009 Aug; 61(8):1005-12. PubMed ID: 19703343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innovations in transdermal drug delivery: formulations and techniques.
    Tiwary AK; Sapra B; Jain S
    Recent Pat Drug Deliv Formul; 2007; 1(1):23-36. PubMed ID: 19075872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdermal electroosmotic flow generated by a porous microneedle array patch.
    Kusama S; Sato K; Matsui Y; Kimura N; Abe H; Yoshida S; Nishizawa M
    Nat Commun; 2021 Jan; 12(1):658. PubMed ID: 33510169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdermal permeation of drugs with differing lipophilicity: Effect of penetration enhancer camphor.
    Xie F; Chai JK; Hu Q; Yu YH; Ma L; Liu LY; Zhang XL; Li BL; Zhang DH
    Int J Pharm; 2016 Jun; 507(1-2):90-101. PubMed ID: 27154251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges and opportunities in dermal/transdermal delivery.
    Paudel KS; Milewski M; Swadley CL; Brogden NK; Ghosh P; Stinchcomb AL
    Ther Deliv; 2010 Jul; 1(1):109-31. PubMed ID: 21132122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Mild Hyperthermia on Transdermal Absorption of Nicotine from Patches.
    Panda A; Sharma PK; Narasimha Murthy S
    AAPS PharmSciTech; 2019 Jan; 20(2):77. PubMed ID: 30635802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanocarriers and their Actions to Improve Skin Permeability and Transdermal Drug Delivery.
    Khan NR; Harun MS; Nawaz A; Harjoh N; Wong TW
    Curr Pharm Des; 2015; 21(20):2848-66. PubMed ID: 25925113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gradient-dependent release of the model drug TRITC-dextran from FITC-labeled BSA hydrogel nanocarriers in the hair follicles of porcine ear skin.
    Tran NBNN; Knorr F; Mak WC; Cheung KY; Richter H; Meinke M; Lademann J; Patzelt A
    Eur J Pharm Biopharm; 2017 Jul; 116():12-16. PubMed ID: 27693856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surfactant-enhanced transdermal delivery by electroporation.
    Murthy SN; Sen A; Hui SW
    J Control Release; 2004 Aug; 98(2):307-15. PubMed ID: 15262421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of urban particulate pollution on skin barrier function and the subsequent drug absorption.
    Pan TL; Wang PW; Aljuffali IA; Huang CT; Lee CW; Fang JY
    J Dermatol Sci; 2015 Apr; 78(1):51-60. PubMed ID: 25680853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.